Sector: Pharmaceuticals & Biotechnology

Small Cap

Nectar Lifesciences Share Price

Q: What is the current share price of Nectar Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 11.72 on the NSE and ₹ 11.74 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Nectar Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 261 Cr.

Q: What are the PE and PB ratios for Nectar Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -0.9, and the Price-to-Book (PB) ratio is 0.4.

Q: What is the 52-Week High and Low for Nectar Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 25.5, and the lowest price was ₹ 9.3.

Q: Who are the major shareholders of Nectar Lifesciences Ltd.?

Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as: Promoter Public Other Institutions FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Q: What is the latest dividend information for Nectar Lifesciences Ltd.?

Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.

Q: What is the shareholding pattern for Nectar Lifesciences Ltd.?

As per the filings for the quarter ending Mar 2026, the approximate shareholding pattern for Nectar Lifesciences Ltd. is: Promoters: 51.8% Domestic Institutional Investors (DII): 4% Foreign Institutional Investors (FII): 0.6% Others (including Public): 0.1%

Nectar Lifesciences Ltd.

₹11.72

-0.26(-2.17%)

Trade Now

8th Jun 2026 | 3:25 PM

NSE : NECLIFE

Open Free Demat Account

Nectar Lifesciences Performance

Price Movement

₹11.72

₹11.55

₹12.10

↘ Today's Low↗ Today's High

1 Year Performance

₹11.72

₹9.30

₹25.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹12.10

Low₹11.55

Open at₹12.10

Prev Close₹11.98

Volumes1.76 L

Avg Price₹11.72

Lower Circuit₹11.39

Upper Circuit₹12.57

Historical Performance

3M High₹14.91

3M Low₹9.30

1 Yr High₹25.50

1 Yr Low₹9.30

3 Yr High₹56.50

3 Yr Low₹9.30

5 Yr High₹56.50

5 Yr Low₹9.30

Summary

As of 08-06-2026 19:20, Nectar Lifesciences Ltd. share price today is ₹0, with a change of ₹-11.98 (-100.00%) from the previous close of ₹11.98. The stock opened at ₹12.1 and traded between ₹11.55 and ₹12.1, with a total traded volume of 176367 shares. The company has a market capitalization of ₹261 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹25.5 and ₹9.3, respectively.

Nectar Lifesciences Ltd. valuation metrics include a P/E ratio of -0.9, EPS of ₹-13.4, and book value of ₹0.40. Profitability indicators show ROE of -50.29%. Nectar Lifesciences Ltd. has reported revenue of ₹285.67 Cr and net profit of ₹-292.89 Cr.

Nectar Lifesciences Ltd. technical indicators include Day RSI at 39.16, Day MFI at 53.51, Day ADX at 22.27. Additional indicators include Commodity Channel Index (CCI) at -127.6 and Williams %R at -92.5. Momentum indicators show Day MACD at -0.11, Day MACD Signal Line at -0.01, DayATR at 0.53. Rate of Change indicators for Nectar Lifesciences Ltd. include ROC125 at -37.08 and ROC21 at -14.16.

Exponential moving averages include EMA5 at ₹11.9, EMA10 at ₹12.1, EMA12 at ₹12.1, EMA20 at ₹12.2, EMA26 at ₹12.2, EMA50 at ₹12.3, EMA100 at ₹13, EMA200 at ₹15.2. Simple moving averages include SMA5 at ₹11.9, SMA10 at ₹12.1, SMA20 at ₹12.4, SMA30 at ₹12.5, SMA50 at ₹11.9, SMA100 at ₹12.6, SMA150 at ₹14.3, SMA200 at ₹14.4.

Support levels for Nectar Lifesciences are placed at First Support ₹11.43, Second Support ₹11.21, Third Support ₹10.88. Resistance levels are seen at First Resistance ₹11.98, Second Resistance ₹12.31, Third Resistance ₹12.53. Nectar Lifesciences Ltd. shareholding pattern shows promoter holding at 51.84%, FII holding at 0.6%, DII holding at 0%, public holding at 43.52%.

Nectar Lifesciences Fundamentals

Market Cap

Below industry Median

261 Cr.

PE Ratio (TTM)

Negative PE TTM

-0.90

Dividend Yield

Net Profit TTM

158% decr over last year

-292.89

Net Profit Growth

158% decr over last year

-292.89

PEG Ratio

Below industry Median

ROE

323% decr over last year

-50.29

Operating Revenue TTM

285.67

Operating Revenue Growth

83% decr over last year

Book Value

Low in industry

0.40

MFI

MFI is mid-range

53.51

RSI

RSI is mid-range

39.16

EPS (TTM)

-13.40

Debt to Equity

Face Value

Operating Profit Margin Qtr.

-653.35

Operating Profit Qtr.

-58.53

Net Profit Qtr.

-67.92

Operating Revenue Qtr.

PB Ratio

0.40

Nectar Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	0	0	5	280.67	430.69
Operating Expense	58.52	1.92	6.04	342.56	585
Operating Profit	-58.52	-1.92	-1.04	-61.89	-154.30
Depreciation	0.08	0.06	0.20	16.52	15.77
Interest	5.90	30.22	0	18.70	17.67
Tax	-19.71	-11.02	-0.18	-33.52	-57.58
Net Profit	-67.92	14.27	-176.01	-63.23	-130.09

Nectar Lifesciences Technicals

Nectar Lifesciences Ltd. EMA & SMA

₹11.72

-0.26 (-2.17%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹11.9

Day EMA10 ₹12.1

Day EMA12 ₹12.1

Day EMA20 ₹12.2

Day EMA26 ₹12.2

Day EMA50 ₹12.3

Day EMA100 ₹13

Day EMA200 ₹15.2

Nectar Lifesciences Support and Resistance

Resistance

First Resistance₹11.98

Second Resistance₹12.31

Third Resistance₹12.53

Support

First Support₹11.43

Second Support₹11.21

Third Support₹10.88

Technical Indicators

Day RSI39.16

Day MFI53.51

Day ADX22.27

Day Commodity Channel Index-127.60

William-92.50

Day MACD-0.11

Day MACD Signal Line-0.01

Day ATR0.53

Day ROC125-37.08

Day ROC21-14.16

Nectar Lifesciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	44.5	44.5	44.5	44.9	44.9	51.8
FII	0.7	1.6	0.8	0.6	0.5	0.6
DII	0.1	0.2	0.2	0.1	5.9	4
Public	54.7	53.6	54.4	54.4	48.7	43.5

Nectar Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.07 L	2.07 L	100.00%
Week	2.24 L	2.24 L	100.00%
1 Month	3.37 L	4.06 L	83.01%
6 Month	6.08 L	7.17 L	84.86%

Nectar Lifesciences SWOT Analysis

Strengths6

Weakness20

Opportunity1

Threats0

Promoter holding increased more than 2% QoQ

Companies with no Debt

PEG lower than Industry PEG

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Nectar Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
11 Sep, 2020	0.05	FINAL	Equity Share
19 Sep, 2019	0.05	FINAL	Equity Share
19 Sep, 2018	0.05	FINAL	Equity Share
20 Sep, 2017	0.05	FINAL	Equity Share
22 Sep, 2016	0.1	FINAL	Equity Share
22 Sep, 2015	0.1	FINAL	Equity Share
21 Aug, 2014	0.1	FINAL	Equity Share
19 Sep, 2013	0.1	FINAL	Equity Share
20 Sep, 2012	0.1	FINAL	Equity Share
21 Sep, 2011	0.1	FINAL	Equity Share

Nectar Lifesciences Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹126	₹550.90	₹6.14	₹108	₹131.65	₹14.15
% Change	N/A	1.05%	-3.91%	-3.57%	-1.38%	1.22%
Revenue TTM (₹ Cr)	-	-	₹83.60	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-34.95	-	₹14.88	₹27.81
PE TTM	61.50	-	-1.50	12.90	34.20	26.90
1 Year Return	-7.48	40.54	523	-14.06	3.85	54.51
ROCE	-	3.56	-5.63	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.55

+0.00%

INFLUX

Influx Healthtech Ltd.

₹ 233.00

-2.51%

GUFICBIO

Gufic BioSciences Ltd.

₹ 377.00

+1.91%

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd.

₹ 197.50

-2.73%

GUJTHEM

Gujarat Themis Biosyn Ltd.

₹ 404.90

-2.01%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 358.15

-1.35%

ANUHPHR

Anuh Pharma Ltd.

₹ 75.50

-0.26%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 420.60

-4.05%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 42.52

-2.81%

LYKALABS

Lyka Labs Ltd.

₹ 63.60

+0.05%

ACCPL

Accretion Pharmaceuticals Ltd.

₹ 137.70

-4.97%

SATKARTAR

Sat Kartar Life Ltd.

₹ 166.00

-0.98%

ONYX

Onyx Biotec Ltd.

₹ 42.00

+0.00%

VAISHALI

Vaishali Pharma Ltd.

₹ 7.30

+0.27%

BALAXI

Balaxi Pharmaceuticals Ltd.

₹ 24.50

+0.91%

QUESTLAB

Quest Laboratories Ltd.

₹ 100.50

-1.47%

ZENITHDRUG

Zenith Drugs Ltd.

₹ 42.95

+5.79%

ACCENTMIC

Accent Microcell Ltd.

₹ 474.10

-0.69%

SUNREST

Sunrest Lifescience Ltd.

₹ 34.00

+0.00%

MONOPHARMA

Mono Pharmacare Ltd.

₹ 11.80

+3.06%

REMUS

Remus Pharmaceuticals Ltd.

₹ 713.00

+1.39%

INFINIUM

Infinium Pharmachem Ltd.

₹ 199.05

-4.07%

JFLLIFE

JFL Life Sciences Ltd.

₹ 9.50

-5.00%

WALPAR

Walpar Nutritions Ltd.

₹ 25.75

-4.98%

FAQ's on NECLIFE

What is the current share price of Nectar Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 11.72 on the NSE and ₹ 11.74 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Nectar Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 261 Cr.

What are the PE and PB ratios for Nectar Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -0.9, and the Price-to-Book (PB) ratio is 0.4.

What is the 52-Week High and Low for Nectar Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 25.5, and the lowest price was ₹ 9.3.

Who are the major shareholders of Nectar Lifesciences Ltd.?

Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Nectar Lifesciences Ltd.?

Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.